| abstract |
A TLR signaling inhibitor, preferably an inhibitor of the production of various cytokines such as IL-8 or an inflammatory mediator, an inhibitor of the expression of COX-II or the like or an inhibitor of various kinases such as ATF2 containing a compound represented by the formula (I) or the formula (II): (I) (II) (wherein the definition of each symbol is as described in the description), a salt thereof or a prodrug thereof. |